David Phear
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Neurological and metabolic disorders
- Diabetes Management and Research
Papers in
-
- Diet and metabolism studies 2
- Surgery 3
- Kawasaki Disease and Coronary Complications 1
- Co-authors
- F. I. R. Martin (1 shared paper)Brian Walker (1 shared paper)Vivian Fonseca (1 shared paper)T S Low-Beer (1 shared paper)Keith Ball (1 shared paper)G. A. Gresham (2 shared papers)Karen L. Ball (1 shared paper)Richard Kimber (1 shared paper)
- Journals
- The Lancet (7 papers)The Medical Journal of Australia (2 papers)Gut (1 paper)The American Journal of Medicine (1 paper)Palliative Medicine (1 paper)
- Partner nations
- United KingdomAustraliaSouth Sudan
In The Last Decade
David Phear
21 papers receiving 246 citations
Peers
Comparison fields: 5 of 73
- Internal Medicine 32
- Endocrinology, Diabetes and Metabolism 55
- Nephrology 23
- Cardiology and Cardiovascular Medicine 63
- Genetics 67
Countries citing papers authored by David Phear
This map shows the geographic impact of David Phear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Phear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Phear more than expected).
Fields of papers citing papers by David Phear
This network shows the impact of papers produced by David Phear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Phear. The network helps show where David Phear may publish in the future.
Co-authors
The 9 scholars most cited alongside David Phear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1963 | 52 | |
| 2 | 1958 | 52 | |
| 3 | 1960 | 49 | |
| 4 | 1968 | 25 | |
| 5 | 1982 | 22 | |
| 6 | 1982 | 20 | |
| 7 | 1961 | 18 | |
| 8 | 1960 | 15 | |
| 9 | 1996 | 14 | |
| 10 | 1957 | 10 | |
| 11 | 1957 | 8 | |
| 12 | 1960 | 8 | |
| 13 | 1970 | 7 | |
| 14 | 1962 | 6 | |
| 15 | 1957 | 5 | |
| 16 | 1957 | 3 | |
| 17 | 1960 | 3 | |
| 18 | Phenmetrazine in the treatment of obesity. | 1959 | 3 |
| 19 | 1963 | 3 | |
| 20 | 1965 | 2 |
About David Phear
David Phear is a scholar working on Physiology, Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 326 indexed citations. Recurring topics across this work include Neurological and metabolic disorders (2 papers), Diet and metabolism studies (2 papers), Signaling Pathways in Disease (1 paper), Ethics and Legal Issues in Pediatric Healthcare (1 paper), Moyamoya disease diagnosis and treatment (1 paper), Cardiac Arrhythmias and Treatments (1 paper), Kawasaki Disease and Coronary Complications (1 paper) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper). The work is most often cited by research in Internal Medicine (32 citations), Endocrinology, Diabetes and Metabolism (55 citations), Nephrology (23 citations), Cardiology and Cardiovascular Medicine (63 citations) and Genetics (67 citations). David Phear has collaborated with scholars based in United Kingdom, Australia and South Sudan. Frequent co-authors include F. I. R. Martin, Brian Walker, Vivian Fonseca, T S Low-Beer, Keith Ball, G. A. Gresham, Karen L. Ball, Richard Kimber and Kelly K. Ball. Their work appears in journals such as The Lancet, The Medical Journal of Australia, Gut, The American Journal of Medicine and Palliative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.